| Financial Year |
March 31 2023 |
| Monetary Funds |
1,889,045,651.71 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
148,949,677.26 |
| Advances to Suppliers |
35,304,707.58 |
| Other Receivables |
821,506.91 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
584,765,776.51 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
34,862,236.28 |
| Total Current Assets |
2,693,749,556.25 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
67,329,933.23 |
| Fixed Assetes |
1,742,119,854.67 |
| Under-construction Projects |
675,895,755.59 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
164,598,710.10 |
| R&D expenses |
30,209,385.93 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
25,132,592.33 |
| Other Non-Current Assets |
36,469,799.47 |
| Sub-Total of Non-Current Assets |
2,741,756,031.32 |
| Total Assets |
5,435,505,587.57 |
| Short-Term Loans |
623,466,130.28 |
| Trading Financial liabilities |
428,100.00 |
| Notes Payable |
26,459,499.22 |
| Accounts Payable |
380,222,030.53 |
| Accounts Received In Advance |
1,749,662.47 |
| Employee Compensation Payable |
10,274,137.14 |
| Taxes Payable |
22,417,417.44 |
| Interest Payable |
246,575.34 |
| Dividend Payable |
-- |
| Other payables |
102,200,603.80 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
93,331,606.00 |
| Other Current Liabilities |
12,262,676.93 |
| Sub-Total of Current Liabilities |
1,367,609,060.45 |
| Long-term Loans |
-- |
| Bonds Payable |
877,599,858.57 |
| Long-Term Accounts Payable |
186,663,212.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
366,860.78 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,124,059,877.18 |
| Total Liabilities |
2,491,668,937.63 |
| Paid-In Capital(Or Share Stock) |
551,007,557.00 |
| Capital Surplus |
-29,193,413.00 |
| Surplus Reserve |
191,916,483.04 |
| LESS:Treasury Stock |
53,723,530.00 |
| Undistributed Profits |
1,971,202,545.63 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,943,836,649.94 |
| Owner's Equity（Stockholder's Equity） |
2,943,836,649.94 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,435,505,587.57 |
